Analysis of 6-month confirmed disability progression in RRMS patients treated with subcutaneous interferon beta-1a

Authors
Category Primary study
ConferenceMultiple Sclerosis Journal
Year 2018
This article has no abstract
Epistemonikos ID: 2bcf16bbe034e28c76f8c0e1f8ad2981a502f577
First added on: Apr 29, 2026